Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Environmental and genetic risk...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Environmental and genetic risk factors for myopathy in Chinese participants from HPS2-THRIVE
Bibliographic Details
Main Authors:
Hopewell, J
,
Offer, A
,
Parish, S
,
Haynes, R
,
Li, J
,
Jiang, L
,
Lathrop, M
,
Armitage, J
,
Collins, R
,
Grp, H
Format:
Conference item
Published:
2012
Holdings
Description
Similar Items
Staff View
Similar Items
Impact of apolipoprotein(a) isoform size on lipoprotein(a) lowering in the HPS2-THRIVE study
by: Parish, S, et al.
Published: (2018)
Effects of extended release niacin/laropiprant in 25,673 high-risk individuals receiving statin-based therapy: the HPS2-THRIVE randomized placebo-controlled trial
by: Landray, M, et al.
Published: (2014)
Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study.
by: Hopewell, J, et al.
Published: (2013)
Serious adverse effects of extended-release niacin/laropiprant: results from the Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events (HPS2-THRIVE) Trial
by: Haynes, R, et al.
Published: (2019)
Independent risk factors for simvastatin-related myopathy and relevance to different types of muscle symptom
by: Hopewell, JC, et al.
Published: (2020)